Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
(R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one → (R)-9-((3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)-N3-methyl-4,5-dihydrobenzo[b]pyrazol o[1,5-d][1,4]oxazepine-2,3-dicarboxamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | (R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one | HCID 86693296 | — |
| 반응물 | 9-bromo-N3-methyl-4,5-dihydrobenzo[b]pyrazolo[1,5-d][1,4]oxazepine-2,3-dicarboxamide | HCID 86693336 | — |
| 생성물 | (R)-9-((3-hydroxy-1-methyl-2-oxopyrrolidin-3-yl)ethynyl)-N3-methyl-4,5-dihydrobenzo[b]pyrazol o[1,5-d][1,4]oxazepine-2,3-dicarboxamide | HCID 86693335 | 25% |
반응 단계
Similar to as described in General Procedure G, 9-bromo-N3-methyl-4,5-dihydrobenzo[b]pyrazolo[1,5-d][1,4]oxazepine-2,3-dicarboxamide was reacted with (R)-3-ethynyl-3-hydroxy-1-methylpyrrolidin-2-one to give the titled compound as a brown solid (32 mg, 25%).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US09034866B2 |
| 출처 데이터셋 | uspto-grants-2015_05 |
| ORD ID | ord-918ec120c7b8416cb69d6ee26822793f |
| 출처 메모 | uspto-grants-2015_05 |